Haemonetics Balance Sheet
NYSE: HAEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Haemonetics financial position
At the end of fiscal 2026, Haemonetics reported total assets of $2.40 billion, down 2.2% from a year earlier against total liabilities of $1.60 billion. Shareholders' equity stood at $796.3 million, or 33.2% of assets. The company held $245.4 million in cash and equivalents against $1.22 billion of debt, a net debt position of $979.1 million.
The current ratio (current assets divided by current liabilities) was 2.95, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.54.
Summary generated from market data by MetaCap's automated system. Methodology
Haemonetics balance sheet (annual)
| Fiscal year (USD) | FY 20262026-03-28 | FY 20252025-03-29 | FY 20242024-03-30 | FY 20232023-04-01 | FY 20222022-04-02 | FY 20212021-04-03 | FY 20202020-03-28 | FY 20192019-03-30 | FY 20182018-03-31 | FY 20172017-04-01 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 245.44M | 306.76M | 178.80M | 284.47M | 259.50M | 192.31M | 137.31M | 169.35M | 180.17M | 139.56M |
| Receivables | 216.85M | 202.66M | 206.56M | 179.14M | 159.38M | 127.56M | 165.21M | 185.03M | 151.23M | 152.68M |
| Inventory | 306.37M | 365.14M | 317.20M | 259.38M | 293.03M | 322.61M | 270.28M | 194.34M | 160.80M | 176.93M |
| Total Current Assets | 834.88M | 934.98M | 768.90M | 769.72M | 756.03M | 693.55M | 603.64M | 576.12M | 521.18M | 510.03M |
| Property, Plant & Equipment | 305.76M | 284.05M | 311.36M | 310.88M | 258.48M | 217.56M | 253.40M | 343.98M | 332.16M | 323.86M |
| Goodwill | 656.37M | 604.27M | 565.08M | 466.23M | 467.29M | 466.44M | 210.65M | 210.82M | 211.40M | 210.84M |
| Intangible Assets | 447.65M | 455.74M | 406.12M | 275.77M | 310.26M | 365.48M | 133.11M | 127.69M | 156.59M | 177.54M |
| Total Assets | 2.40B | 2.45B | 2.20B | 1.93B | 1.86B | 1.82B | 1.27B | 1.27B | 1.24B | 1.24B |
| Accounts Payable | 51.06M | 67.00M | 73.36M | 63.93M | 58.37M | 50.29M | 50.73M | 63.36M | 55.27M | 42.97M |
| Short-Term Debt | 5.01M | 303.56M | 10.23M | 11.78M | 214.15M | 17.02M | 76.98M | 27.67M | 194.26M | 61.02M |
| Total Current Liabilities | 282.60M | 578.11M | 300.38M | 251.82M | 442.27M | 253.50M | 274.82M | 235.76M | 384.70M | 211.18M |
| Long-Term Debt | 1.22B | 921.23M | 797.56M | 754.10M | 559.44M | 690.59M | 305.51M | 322.45M | 59.42M | 253.63M |
| Total Liabilities | 1.60B | 1.63B | 1.24B | 1.12B | 1.11B | 1.09B | 680.00M | 606.90M | 484.91M | 499.10M |
| Shareholders' Equity | 796.32M | 820.84M | 959.96M | 818.00M | 749.42M | 731.67M | 587.11M | 667.87M | 752.43M | 739.61M |
| Retained Earnings | 279.34M | 352.17M | 360.46M | 253.17M | 202.39M | 157.98M | 78.51M | 161.42M | 266.94M | 289.92M |
| Total Debt | 1.22B | 1.22B | 807.79M | 765.89M | 773.59M | 707.61M | 382.49M | 350.12M | 253.68M | 314.65M |
| Net Cash (Debt) | -979.14M | -918.02M | -628.99M | -481.42M | -514.09M | -515.30M | -245.18M | -180.77M | -73.51M | -175.08M |
| Shares Outstanding | 45.25M | 48.22M | 50.79M | 50.45M | 51.12M | 50.87M | 50.32M | 51.02M | 52.34M | 52.26M |
This table shows 10 annual periods of Haemonetics's balance sheet, from FY 2026 back to FY 2017, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow HAE's reporting calendar. What is a balance sheet?